To determine whether ATG5 could be used as biomarkers for prognosis of CRC, the relationship of ATG5 with the overall survival and disease-free survival (DFS) was initially examined by a Kaplan–Meier curve analysis (Figure 1B,C). This evidence concerns the gene ATG5 and colorectal carcinoma.